|
DBVT
|
DBV Technologies S.A.
|
US
|
NASDAQ
|
|
DTIL
|
Precision BioSciences, Inc.
|
US
|
NASDAQ
|
|
ENLV
|
Enlivex Therapeutics Ltd.
|
US
|
NASDAQ
|
|
ERNA
|
Eterna Therapeutics Inc.
|
US
|
NASDAQ
|
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FBIOP
|
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
|
US
|
NASDAQ
|
|
GLSI
|
Greenwich LifeSciences, Inc.
|
US
|
NASDAQ
|
|
GNCA
|
Genocea Biosciences, Inc.
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HGEN
|
Humanigen, Inc.
|
US
|
NASDAQ
|
|
IBRX
|
ImmunityBio, Inc.
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
US
|
NASDAQ
|
|
IMNN
|
Imunon, Inc.
|
US
|
NASDAQ
|
|
IMRN
|
Immuron Limited
|
US
|
NASDAQ
|
|
IMTX
|
Immatics N.V.
|
US
|
NASDAQ
|
|
IMUX
|
Immunic, Inc.
|
US
|
NASDAQ
|
|
IMV
|
IMV Inc.
|
US
|
NASDAQ
|
|
INDP
|
Indaptus Therapeutics, Inc.
|
US
|
NASDAQ
|